RedPath Integrated Pathology's Series C Round

RedPath Integrated Pathology raised a round of funding on May 16, 2011.

RedPath Integrated Pathology is a genomics-based molecular diagnostics company that provides cancer diagnostic testing for pathologists, oncologists and clinicians. The company's CLIA licensed, CAP ce…

Articles about RedPath Integrated Pathology's Series C Round: